HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms.

AbstractUNLABELLED:
Constitutive activation of NF-κB is a hallmark of the activated B cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL), owing to upstream signals from the B-cell receptor (BCR) and MYD88 pathways. The linear polyubiquitin chain assembly complex (LUBAC) attaches linear polyubiquitin chains to IκB kinase-γ, a necessary event in some pathways that engage NF-κB. Two germline polymorphisms affecting the LUBAC subunit RNF31 are rare among healthy individuals (∼1%) but enriched in ABC DLBCL (7.8%). These polymorphisms alter RNF31 α-helices that mediate binding to the LUBAC subunit RBCK1, thereby increasing RNF31-RBCK1 association, LUBAC enzymatic activity, and NF-κB engagement. In the BCR pathway, LUBAC associates with the CARD11-MALT1-BCL10 adapter complex and is required for ABC DLBCL viability. A stapled RNF31 α-helical peptide based on the ABC DLBCL-associated Q622L polymorphism inhibited RNF31-RBCK1 binding, decreased NF-κB activation, and killed ABC DLBCL cells, credentialing this protein-protein interface as a therapeutic target.
SIGNIFICANCE:
We provide genetic, biochemical, and functional evidence that the LUBAC ubiquitin ligase is a therapeutic target in ABC DLBCL, the DLBCL subtype that is most refractory to current therapy. More generally, our findings highlight the role of rare germline-encoded protein variants in cancer pathogenesis.
AuthorsYibin Yang, Roland Schmitz, Joseph Mitala, Amanda Whiting, Wenming Xiao, Michele Ceribelli, George W Wright, Hong Zhao, Yandan Yang, Weihong Xu, Andreas Rosenwald, German Ott, Randy D Gascoyne, Joseph M Connors, Lisa M Rimsza, Elias Campo, Elaine S Jaffe, Jan Delabie, Erlend B Smeland, Rita M Braziel, Raymond R Tubbs, James R Cook, Dennis D Weisenburger, Wing C Chan, Adrian Wiestner, Michael J Kruhlak, Kazuhiro Iwai, Federico Bernal, Louis M Staudt
JournalCancer discovery (Cancer Discov) Vol. 4 Issue 4 Pg. 480-93 (Apr 2014) ISSN: 2159-8290 [Electronic] United States
PMID24491438 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Peptides
  • Transcription Factors
  • RBCK1 protein, human
  • RNF31 protein, human
  • Ubiquitin-Protein Ligases
  • Protein Serine-Threonine Kinases
  • NF-kappa B kinase
Topics
  • Binding Sites
  • Cell Line, Tumor
  • Circular Dichroism
  • Genetic Variation
  • Germ-Line Mutation
  • Humans
  • Lymphoma, Large B-Cell, Diffuse (genetics, pathology)
  • Models, Molecular
  • Peptides (chemical synthesis, pharmacology)
  • Polymorphism, Single Nucleotide
  • Protein Serine-Threonine Kinases (metabolism)
  • Protein Structure, Secondary
  • Transcription Factors (metabolism)
  • Ubiquitin-Protein Ligases (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: